Lower Urinary News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lower Urinary. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lower Urinary Today - Breaking & Trending Today

Alnylam Announces FDA Approval of Supplemental New Drug Application for OXLUMO® (lumasiran) in Advanced Primary Hyperoxaluria Type 1 - Alnylam Pharmaceuticals (NASDAQ:ALNY) - Press Release

Published: October 7, 2022

- OXLUMO Now Indicated for the Treatment of Primary Hyperoxaluria Type 1 (PH1) to Lower Urinary and Plasma Oxalate Levels in Pediatric and Adult Patie

Source: wiredprnews.com

Related Topics:

United StatesUnited KingdomJorge CapapeyKim HollanderHyperoxaluria FoundationGlobal Rare Disease Lead At Alnylam PharmaceuticalsDrug AdministrationAlnylam Pharmaceuticals IncExchange CommissionAlnylam PharmaceuticalsEuropean Medicines AgencyCommittee For Medicinal Products Human UsePrimary Hyperoxaluria TypeLower UrinaryPlasma Oxalate LevelsAdult PatientsPositive EfficacySafety ResultsSevere Renal ImpairmentIncluding ThoseNew Drug ApplicationVice PresidentGlobal Rare Disease LeadMonth SixExecutive Director